Evolus (EOLS) Misses Q4 EPS by 6c; Offers Guidance

Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $43.65 million versus the consensus estimate of $43.89 million.

GUIDANCE:

Evolus sees FY2023 revenue of $180-190 million, versus the consensus of $187.1 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.

You May Also Be Interested In

• HSBC sees more upside in Intel stock on server CPU opportunity
• Middleby completes spin-off of food processing unit as Midera
• Incyte acquires Vega Therapeutics for $1.25B upfront